Efficacy and Safety of Lactobacillus plantarum DSM 9843 (LP299V) in the Prevention of Antibiotic-Associated Gastrointestinal Symptoms in Children—Randomized, Double-Blind, Placebo-Controlled Study

Journal of Pediatrics

Volumn 186, Issue , 2017, Pages 82-86

  Olek, Agnieszka ^a   Woynarowski, Marek ^a,b   Ahrén, Irini Lazou ^c   Kierkuś, Jarosław ^a,b   Socha, Piotr ^b   Larsson, Niklas ^c   Önning, Gunilla ^c  

^a Medical Network   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c Probi AB   (Sweden)

Author keywords

diarrhea; probiotics

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; MACROLIDE; PENICILLIN DERIVATIVE; PLACEBO; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ANOREXIA; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BRISTOL STOOL FORM SCALE; CHILD; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EAR INFECTION; FEMALE; FEVER; FLATULENCE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INCIDENCE; LACTOBACILLUS PLANTARUM; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PATIENT COMPLIANCE; PHARYNGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; RATING SCALE; RESPIRATORY TRACT INFECTION; RISK REDUCTION; URINARY TRACT INFECTION; VOMITING; CHEMICALLY INDUCED; DIARRHEA; PRESCHOOL CHILD; TREATMENT OUTCOME;

ABDOMINAL PAIN; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; LACTOBACILLUS PLANTARUM; MALE; PROBIOTICS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85018653355     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2017.03.047     Document Type: Article

References (17)

1. MOST, WHO, UNICEF, IZiNCG, Diarrhea Treatment Guidelines (including new recommendations for the use of ORS and zinc supplementation) for Clinic-Based Healthcare Workers. http://www.who.int/child-adolescent-health/Emergencies/Diarrhoea_guidelines.pdf, 2005.
2. Johnston, B.C., Goldenberg, J.Z., Vandvik, P.O., Sun, X., Guyatt, G.H., Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev(11), 2011 CD004827.
3. Araya, M., Morelli, L., Reid, G., Sanders, M.E., Stanton, C., Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food; London Ontario, Canada 30.04-1.05. 2002.
4. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11 (2014), 506–514.
5. Szajewska, H., Fordymacka, A., Bardowski, J., Górecki, R.K., Mrukowicz, J.Z., Banaszkiewicz, A., Microbiological and genetic analysis of probiotic products licensed for medicinal purposes. Med Sci Monit 10 (2004), 346–350.
6. Adlerberth, I., Ahrne, S., Johansson, M.L., Molin, G., Hanson, L.A., Wold, A.E., A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29. Appl Environ Microbiol 62 (1996), 2244–2251.
7. Mack, D.R., Michail, S., Wei, S., McDougall, L., Hollingsworth, M.A., Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276 (1999), G941–50.
8. Waugh, A.W.G., Foshaug, R., MacFarlane, S., Doyle, J.S.G., Churchill, T.A., Sydora, B.C., et al. Effects of Lp299v treatment in an animal model of irritable bowel syndrome. Microb Ecol Health Dis 21 (2009), 33–37.
9. Schultz, M., Veltkamp, C., Dieleman, L.A., Grenther, W.B., Wyrick, P.B., Tonkonogy, S.L., et al. Lactobacillus plantarum 299v in the treatment and prevention of spontaneous colitis in IL-10 deficient mice. Inflamm Bowel Dis 8 (2002), 71–80.
10. Johansson, M.L., Noaek, S., Berggren, A., Nyman, M., Björck, I., Ahrné, S., et al. Survival of Lp299v and effects on short chain fatty acid chain content after ingestion of rose-hip drink with fermented oats. Int J Food Microbiol 42 (1998), 29–38.
11. Goossens, D., Jonkers, D., Russel, M., Stobberingh, E., Van Den Bogaard, A., StockbrUgger, R., The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects. Aliment Pharmacol Ther 18 (2003), 495–505.
12. Mangell, P., Nejdfors, P., Wang, M., Ahrné, S., Weström, B., Thorlacius, H., et al. Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability. Dig Dis Sci 47 (2002), 511–516.
13. Lönnermark, E., Friman, V., Lappas, G., Sandberg, T., Berggren, A., Adlerberth, I., Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol 44 (2010), 106–112.
14. Kotowska, M., Albrecht, P., Szajewska, H., Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 21 (2005), 583–590.
15. Ruszczynski, M., Radzikowski, A., Szajewska, H., Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E / N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharmacol Ther 28 (2008), 154–161.
16. Olek, A., Woynarowski, M., Kierkuś, J., Socha, J., Kuran, B., Joński-Jastrzębowski, S., et al. Parents expectations and practice of probiotics use in children during antibiotic therapy. Stand Med 12 (2015), 1071–1078.
17. McFarland, L.V., Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol 3 (2008), 563–578.